AGMB
AgomAb Therapeutics NV
NASDAQ · Healthcare · Biotechnology · BE
$8.23
−0.60%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.65x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 1.37x
Liquidity & coverage
- Current ratio
- 6.52x
- Quick ratio
- 6.52x
- Cash ratio
- 6.27x
- Interest coverage
- -987.92x
- EBITDA / interest
- —
- Working capital
- $115.2M
Cash & dividend
- FCF / debt
- -41.26x
- Cash flow / debt
- -41.26x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025